What Is: Xenobots

Scientific Frontline: Extended "At a Glance" Summary: What Are Xenobots? Programmable Biological Organisms

The Core Concept: Xenobots are microscopic, programmable biological machines constructed entirely from living cells without any genetic modification. Measuring less than a millimeter, they lack traditional mechanical parts and are entirely organic, biodegradable, and derived primarily from embryonic stem cells of the African clawed frog (Xenopus laevis).

Key Distinction/Mechanism: Unlike inorganic robots engineered with deterministic algorithms, Xenobots are developed using evolutionary algorithms on a supercomputer to optimize biological architectures for specific behavioral goals. They rely on morphological computation and autonomous self-assembly to exhibit ciliary locomotion, molecular memory, swarm intelligence, and kinematic self-replication—a purely mechanical, non-genetic form of reproduction.

Major Frameworks/Components:

• In Silico Morphogenesis: Supercomputer-driven evolutionary algorithms simulate and optimize cellular configurations, applying specific constraints and noise injection to overcome the "sim-to-real gap".
• Kinematic Self-Replication: Utilizing an AI-optimized "Pac-Man" topology to mechanically corral free-floating stem cells into functional offspring, effectively decoupling biological reproduction from genetic division.
• Transcriptomic Plasticity: An inherent cellular adaptation resulting in a "phylostratigraphic shift" toward ancient evolutionary gene expressions when stem cells are isolated from standard embryonic developmental pathways.
• Human-Derived Anthrobots: Motile, multicellular spheroids spontaneously cultivated from adult human tracheal cells that have demonstrated the ability to autonomously bridge and regenerate severed neural tissue in vitro.
• Neurobots: Engineered biobots augmented with neural precursor cells that successfully self-organize into functioning, calcium-firing neural networks capable of autonomous visual gene expression despite lacking eyes.

Nanoscale drug factory helps cells make medicine from within

Image Credit: Courtesy of King Abdullah University of Science and Technology

Scientific Frontline: Extended "At a Glance" Summary: Nanoscale Drug Factories

The Core Concept: Scientists have engineered synthetic organelles using tiny sponge-like particles to transport a team of six proteins into living cells, creating a nanoscale factory that produces therapeutic compounds directly inside the cell.

Key Distinction/Mechanism: Unlike conventional therapies that struggle to deliver more than one or two proteins into a cell, this "protein pathway transplant" packages an integrated six-protein system within porous metal-organic frameworks (MOFs). These protective scaffolds allow the proteins to remain active and work sequentially to convert amino acids into complex biomolecules.

Major Frameworks/Components:

• Metal-Organic Frameworks (MOFs): Highly porous, sponge-like nanoparticle scaffolds designed to protect protein payloads without stripping their biological activity.
• Synthetic Organelles: Artificial, engineered structures that mimic the key metabolic functions of natural cell components.
• Protein Pathway Transplant: The coordinated delivery of a fully integrated, six-protein bacterial biosynthesis pathway.
• Violacein Production System: The specific proof-of-concept pathway where the introduced protein system successfully converts a simple amino acid into a natural bioactive compound (violacein).

Synthetic biology leads to recyclable textiles: Engineered protein fibers for a cleaner future

The hair-like fiber pictured here is a sample of SAM, silk-amyloid-mussel protein hybrid, an engineered protein polymer that can be easily recycled and reused when dropped in a solvent.
Photo Credit: McKelvey School of Engineering

Scientific Frontline: Extended "At a Glance" Summary: Engineered Protein Fibers (SAM)

The Core Concept: Silk-amyloid-mussel (SAM) protein hybrids are bioengineered materials produced by genetically modified microbes that serve as a fully recyclable, biodegradable alternative to synthetic textiles.

Key Distinction/Mechanism: Unlike petrochemical plastics that degrade in quality during recycling, SAM fibers dissolve rapidly in a formic acid solvent, breaking the structural bonds without altering the underlying proteins. Once the solvent evaporates, the raw proteins can be reconstituted into fibers with their original strength.

Major Frameworks/Components:

• Genetically Engineered Microbes: Utilized within bioreactors to synthesize the raw protein polymers.
• Mussel Foot Proteins: Genetic sequences integrated to control solubility in formic acid and prevent the material from shrinking when exposed to water.
• Spider Silk and Amyloids: Protein sequences that provide high tensile strength and ensure the polymer chains reconnect robustly after the recycling process.
• Formic Acid Solvent: A volatile, industry-standard solution used to safely dissolve the fibers for closed-loop recycling.

Death-defying protein found in tardigrades preserves synthetic cells

Yongkang Xi, Research Fellow for Mechanical Engineering, observes a microscopic image of tardigrade proteins within vesicles at GG Brown on North Campus of the University of Michigan in Ann Arbor, MI
Photo Credit: Jeremy Little, Michigan Engineering

Scientific Frontline: Extended "At a Glance" Summary: Tardigrade CAHS12 Protein and Synthetic Cell Preservation

The Core Concept: The cytoplasmic abundant heat-soluble protein (CAHS12), naturally found in resilient microscopic tardigrades, can be utilized to preserve the structural integrity and biological function of synthetic cells during extreme dehydration. By replicating this natural survival mechanism, scientists can dry out and successfully rehydrate biological materials without causing cellular death.

Key Distinction/Mechanism: While dehydration typically destroys conventional animal cells, the CAHS12 protein reacts to water loss by binding to the fat molecules in the cell membrane. The proteins link together to self-assemble a 3D gel network that physically stabilizes the cell's surface and internal biological machinery. Upon rehydration, this matrix seamlessly dissolves, restoring the cell's normal function.

Major Frameworks/Components: 

• CAHS12 Protein: The specific tardigrade-derived protein responsible for forming protective biological structures under environmental stress.
• Coarse-Grained Molecular Dynamics: Computer simulations utilized to mathematically model how the protective gel matrix self-assembles and interacts with the cell membrane during dehydration.
• Dehydration-Rehydration Cycling: The experimental framework proving that synthetic cells equipped with CAHS12 retain complex internal machinery, such as the ability to read DNA and produce fluorescent proteins, post-rehydration.
• Biological Microfactories: Synthetic cellular constructs made of lipids, proteins, and nucleic acids engineered for targeted molecular production.

Gene circuits reshape DNA folding and affect how genes are expressed

When a gene turns on, it creates structural ripples along DNA that can activate or suppress neighboring genes, MIT researchers find.
Image Credit: Scientific Frontline

Scientific Frontline: Extended "At a Glance" Summary: Gene Syntax and DNA Folding

The Core Concept: When a gene is transcribed, it creates physical ripples along the DNA strand that can either activate or suppress neighboring genes. The physical ordering and arrangement of these genes, known as "gene syntax," directly dictates how their structural interactions couple their expression.

Key Distinction/Mechanism: While traditional synthetic gene circuits rely primarily on biochemical components (like repressor or activator molecules) to control output, this approach utilizes the biophysical manipulation of the DNA polymer itself. Transcription unwinds the DNA helix, making the strand looser upstream (easier for RNA polymerase to attach) and more tightly wound downstream (forming twisted structures called plectonemes that hinder binding).

Origin/History: The foundational concept was proposed through computational modeling in 2022 by MIT researchers Katie Galloway and Christopher Johnstone. In April 2026, the team published a breakthrough study in Science confirming these predicted phenomena in human cells.

Synthetic Biology: In-Depth Description

Synthetic biology is a multidisciplinary area of research that involves the design and construction of novel biological parts, devices, and systems, as well as the re-design of existing, natural biological systems for useful purposes. Its primary goal is to apply rigorous engineering principles to biology, allowing scientists to program biological cells much like computers, thereby enabling organisms to produce new substances, respond to specific environmental cues, or perform entirely new functions that do not exist in nature.

Scientists pave the way for fast, cost-effective custom enzyme development

The SMART single-molecule display model, predicted by Alphafold3, shows SpDAAO (red) linked to a puromycin linker (magenta) through puromycin incorporation into the growing polypeptide. The mRNA (gray) is hybridized and chemically joined to the linker, connecting it to its protein, SpDAAO. An auxiliary unit is added using ORC hairpin DNA (blue) with APEX2-scCro fusion protein (green).
Image Credit: Hideo Nakano and Jasmina Damnjanović

Scientific Frontline: Extended "At a Glance" Summary: SMART Method for Custom Enzyme Development

The Core Concept: SMART (Single-Molecule Assay on Ribonucleic acid by Translated product) is an advanced in vitro selection platform designed to accelerate directed enzyme evolution. It significantly reduces the time and cost required to identify superior enzyme variants by tracking them at the single-molecule level.

Key Distinction/Mechanism: Unlike traditional directed evolution, which often requires screening up to 100 trillion candidate variants over several weeks, the SMART system links an enzyme protein directly to its corresponding messenger RNA (mRNA) blueprint using puromycin as a chemical bridge. An auxiliary unit utilizing engineered ascorbate peroxidase 2 (APEX2) detects target enzyme activity by attaching a biotin marker to nearby molecules, allowing for rapid isolation and capture of the successful variants.

Origin/History: Developed by a collaborative research group led by Nagoya University, the Institute of Science Tokyo, and Saitama University, the SMART method builds upon the Nobel Prize-winning strategy of directed evolution. The findings, which demonstrate the system's ability to reduce screening time from weeks to just a few days without the need for specialized equipment, were published in ACS Synthetic Biology.

Study Finds Each Protein in the Epigenome Produces a Different Pattern of Gene Expression

Image Credit: MJH Shikder.

Scientific Frontline: Extended "At a Glance" Summary: Epigenome Regulators and Dynamic Gene Expression

The Core Concept: Epigenome regulators are specialized proteins bound to DNA that control gene expression not merely as simple on/off switches, but by producing distinct, uniquely patterned behaviors and expression dynamics for specific genes.

Key Distinction/Mechanism: Instead of binary activation, each epigenome-regulating protein influences the timing, strength, and duration of gene expression differently. Some trigger rapid but brief spikes, some sustain long-term activation after initial delays, and others produce consistent or intentionally variable (noisy) expression patterns across individual cells through graded transitions.

Major Frameworks/Components:

• Optogenetic Recruitment: The use of light to precisely control the binding of 87 distinct chromatin-associated proteins to a target gene in yeast organisms.
• Live-Cell Microscopy: Real-time, single-cell observation utilized over a 12-hour period to measure the resultant dynamic gene expression.
• Three-State Kinetic Model: A computational framework incorporating three promoter states and a positive feedback loop, which successfully captured the diverse data and dynamic profiles produced by each protein.

What Is: Synthetic Biology

Scientific Frontline: Extended "At a Glance" Summary: Synthetic Biology

The Core Concept: Synthetic biology is a transformative discipline that merges the biological sciences with rigorous, quantitative engineering principles to fundamentally redesign genetic sequences and construct entirely new biological parts, devices, and systems from the ground up.

Key Distinction/Mechanism: Unlike traditional "top-down" genetic engineering, which relies on retrofitting existing, naturally occurring cells by splicing or modifying small collections of genes, synthetic biology utilizes a predictable, "bottom-up" approach. It treats biology as an engineering discipline, building complex biological circuits and dynamic cellular functions entirely from scratch using rational design and computer science.

Major Frameworks/Components:

• Core Engineering Principles: The strict enforcement of standardization, modularity, and abstraction to bypass biological chaos and render cellular processes as predictable as microchip manufacturing.
• The Abstraction Hierarchy: A multi-tiered framework designed to manage biological complexity by intentionally hiding information across four levels: DNA (informational substrate), Bioparts/BioBricks (standardized sequences encoding isolated functions), Devices (assembled parts for specific tasks like logic gates), and complex Biological Systems functioning within a host cell "chassis."
• The Design-Build-Test-Learn (DBTL) Cycle: An iterative manufacturing workflow reliant on computer-aided design (CAD) and thermodynamic simulations (Design), automated gene synthesis and robotics (Build), high-throughput screening and multi-omics (Test), and artificial intelligence/machine learning for data parsing (Learn).

Engineered yeast gives the U.S. a green edge in the critical minerals market

Researchers genetically engineered the metabolic pathways in yeast to produce oxalic acid, which can be used to extract free rare earth elements from low-grade ore.
Graphic Credit: Courtesy Dan Herchek/LLNL

Scientific Frontline: Extended "At a Glance" Summary: Engineered Yeast for Rare Earth Element Recovery

The Core Concept: A novel, environmentally sustainable biomanufacturing process that utilizes genetically engineered yeast to produce oxalic acid, which is subsequently used to extract and purify free rare-earth elements (REEs) from low-grade ore.

Key Distinction/Mechanism: Conventional oxalic acid production relies on strong acids and generates environmentally hazardous byproducts. In contrast, this new method employs a low-pH-tolerant yeast strain (Issatchenkia orientalis) with modified metabolic pathways to convert glucose directly into oxalic acid. The resulting fermentation broth acts as an oxidizer that selectively binds to REEs, precipitating them into a solid state with over 99% efficiency while leaving unwanted "junk" metals (like zinc) dissolved in solution.

Origin/History: It was developed through a collaboration between the University of Illinois Urbana-Champaign, Lawrence Livermore National Laboratory (LLNL), and the University of Kentucky, in response to a Defense Advanced Research Projects Agency (DARPA) solicitation aimed at utilizing environmental microbes as bioengineering resources.

Programmable proteins use logic to improve targeted drug delivery

Therapies that are sensitive to multiple biomarkers could allow medicines to reach only the areas of the body where they are needed. The diagram above shows three theoretical biomarkers that are present in specific, sometimes overlapping areas of the body. A therapy designed to find the unique area of overlap between the three will act on only that area.
Image Credit: DeForest et al./Nature Chemical Biology

Targeted drug delivery is a powerful and promising area of medicine. Therapies that pinpoint the exact areas of the body where they’re needed — and nowhere they’re not — can reduce the medicine dosage and avoid potentially harmful “off target” effects elsewhere in the body. A targeted immunotherapy, for example, might seek out cancerous tissues and activate immune cells to fight the disease only in those tissues.

The tricky part is making a therapy truly “smart,” where the medicine can move freely through the body and decide which areas to target.

Scientists use quantum biology, AI to sharpen genome editing tool

ORNL scientists developed a method that improves the accuracy of the CRISPR Cas9 gene editing tool used to modify microbes for renewable fuels and chemicals production. This research draws on the lab’s expertise in quantum biology, artificial intelligence and synthetic biology.
Illustration Credit: Philip Gray/ORNL, U.S. Dept. of Energy

Scientific Frontline: Extended "At a Glance" Summary: Enhancing CRISPR Cas9 with Quantum Biology and AI

The Core Concept: Scientists have combined principles of quantum biology with explainable artificial intelligence (AI) to significantly improve the accuracy and efficiency of the CRISPR Cas9 genome editing tool for modifying microbes.

Key Distinction/Mechanism: While traditional CRISPR models were developed for mammalian or model species and often failed in microbes due to differing chromosomal structures, this new approach analyzes the quantum chemical properties of nucleotides (like electron distribution). An explainable AI model is then used to predict the most effective guide RNAs, ensuring the Cas9 enzyme binds successfully to the targeted microbial DNA.

Major Frameworks/Components: 

• CRISPR Cas9 Machinery: A powerful bioengineering tool that uses a unique guide RNA to direct an enzyme to cleave and modify specific genetic code.
• Quantum Biology: A field bridging molecular biology and quantum chemistry, used here to investigate how the electronic structures of nucleotides affect chemical reactivity and conformational stability.
• Explainable Artificial Intelligence (Iterative Random Forest): An interpretable AI model trained on roughly 50,000 guide RNAs targeting E. coli. Unlike "black box" algorithms, it reveals the specific molecular mechanisms and rules that dictate optimal cutting efficiency.
• Functional Genomics: The biological discipline of linking specific genetic codes (genotype) to physical traits (phenotype).

Rice scientists reengineer cancer drugs to be more versatile

Rice University scientists have enlisted widely used cancer therapy systems to control gene expression in mammalian cells, a feat of synthetic biology that could change how diseases are treated.
Photo Credit: Jeff Fitlow/Rice University

Scientific Frontline: Extended "At a Glance" Summary: Engineered PROTAC-CID Systems

The Core Concept: Proteolysis targeting chimeras (PROTACs), highly specific small molecules traditionally used as cancer therapies, have been reengineered by scientists to function as genetic switches that precisely control and induce gene expression in mammalian cells.

Key Distinction/Mechanism: While standard PROTACs function by targeting specific oncogenic proteins and flagging them for targeted degradation, this novel approach repurposes their molecular infrastructure to achieve chemically induced dimerization (CID). In this reengineered system, the small molecules act as inducers that bind two proteins together to turn targeted gene expression on or off, granting unprecedented spatial and temporal control over genetic activation rather than destroying the target protein.

Major Frameworks/Components:

• PROTACs (Proteolysis Targeting Chimeras): Small molecules traditionally utilized to target and disintegrate harmful, disease-causing proteins without prompting drug resistance.
• Chemically Induced Dimerization (CID): A biological mechanism in which two distinct proteins bind together exclusively in the presence of a specific third molecule, known as an inducer.
• Temporal and Spatial Control: A regulatory framework where the natural metabolization of small molecules dictates the duration of gene expression (temporal), and localized delivery restricts activity to specific organs to prevent systemic toxicity (spatial).

Pioneering research using bacteria brings scientists a step closer to creating artificial cells with lifelike functionality

Amoeba-shaped bacteriogenic protocell: membrane (red boundary); nucleus (blue); cytoskeleton (red filaments); vacuole (red circle); ATP production (green). Scale bar, 5 μm.
Credit: Professor Stephen Mann and Dr Can Xu

Scientific Frontline: Extended "At a Glance" Summary: Bacteriogenic Protocells

The Core Concept: Bacteriogenic protocells are advanced synthetic cells constructed by trapping live bacteria within and upon viscous micro-droplets. These structures successfully mimic real-life cellular functionality by utilizing retained bacterial components to produce energy and synthesize proteins.

Key Distinction/Mechanism: While previous attempts to model protocells relied on empty microcapsules with limited capabilities, this approach utilizes a living-material assembly process. By incorporating two types of bacteria into micro-droplets and subsequently destroying them, the process leaves behind thousands of active biological molecules, genetic machinery, and cellular parts integrated directly into the membrane and interior of the synthetic cell.

Major Frameworks/Components: 

• Micro-Droplet Assembly: The foundational step where one population of bacteria is spontaneously captured within viscous droplets while another is trapped at the surface.
• Structural Remodeling: The targeted destruction of the bacteria, which releases components that condense into a single nucleus-like structure, a cytoskeletal-like network of protein filaments, and membrane-bounded water vacuoles.
• Self-Sustainable Energization: The implantation of living bacteria into the protocells to drive self-sustaining ATP production (via glycolysis), ongoing in vitro gene expression, and cytoskeletal assembly.
• Bionic Integration: The resulting cellular bionic system adopts an amoeba-like external morphology driven by on-site bacterial metabolism and growth.

Team Builds First Living Robots That Can Reproduce

Scientific Frontline: Extended "At a Glance" Summary: Xenobots (Self-Replicating Living Robots)

The Core Concept: Xenobots are the world’s first self-replicating living robots, computer-designed and hand-assembled from the embryonic cells of the Xenopus laevis frog.

Key Distinction/Mechanism: Unlike plants, animals, or viruses, Xenobots reproduce through a process called "kinematic replication." The AI-optimized, Pac-Man-shaped parent organisms swim around their environment to gather loose single cells into their "mouths," compressing them to assemble "baby" Xenobots that eventually mature and replicate themselves.

Origin/History: The initial creation of Xenobots was reported in 2020 by scientists from the University of Vermont, Tufts University, and Harvard University's Wyss Institute. The breakthrough regarding their ability to spontaneously self-replicate was published on November 29, 2021, in the Proceedings of the National Academy of Sciences.

Pathways to production

A graphic illustration of the kind of retrosynthetic analysis conducted by RetSynth software developed at Sandia National Laboratories. Using a novel algorithm, the software identifies the biological or chemical reactions needed to create a desired biological product or compound.
(Graphic by Laura Hatfield)

Scientific Frontline: "At a Glance" Summary: Pathways to Production

• Main Discovery: Biologists at Sandia National Laboratories developed a stand-alone software program called RetSynth that uses a novel algorithm to sort through large, curated databases of biological and chemical reactions.
• Methodology: The platform employs retrosynthetic analysis to map out the biological and chemical steps required to engineer and modify cellular molecules, rapidly evaluating all possible production pathways to determine the most efficient sequences.
• Key Data: The software algorithm optimizes manufacturing routes based on specific metrics: the fewest required steps, the highest economic viability utilizing available resources, and the maximum achievable theoretical yield of the desired bioproduct.
• Significance: This technology substantially accelerates the traditionally slow research and development process for bioproduction by rendering clear visual pathways and offering customizable biological, chemical, or hybrid production options.
• Future Application: The software is being commercially licensed to dramatically reduce manufacturing waste and emissions while producing next-generation therapeutics, biofuels, industrial chemicals, cosmetics, and agricultural compounds.
• Branch of Science: Synthetic Biology, Computational Biology, Bioengineering.